gimli
PLPHAR-RE stock analysis context
PIRAMAL PHARMA Stock Context for AI Screening
PIRAMAL PHARMA LIMITED is a stock in Unclassified. This page summarizes key screening signals for PIRAMAL PHARMA, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Open interactive PLPHAR-RE stock pagePrice
₹n/a
1W return
n/a
1M return
n/a
3M return
n/a
6M return
n/a
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
n/a
Turnover
₹n/a
Why it can matter in screens
- Momentum: PLPHAR-RE is trend mixed or unavailable; RSI is n/a.
- Returns: 1D n/a, 1W n/a, 1M n/a, 3M n/a, 1Y n/a.
- Trend levels: 52W high ₹n/a, 52W low ₹n/a, off high n/a.
- Liquidity: latest turnover is ₹n/a; volume vs 20D is n/a.
- Valuation/profitability: PE n/a, PB n/a, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Financials and Ownership
Quarterly income statement
No recent data available.
Annual income statement
No recent data available.
Balance sheet
No recent data available.
Cash flow
No recent data available.
Shareholding Trend
No recent data available.
Industry Peers
No recent data available.
Try these prompts
- Analyze PIRAMAL PHARMA with valuation, momentum and industry peers
- Compare PLPHAR-RE with other Unclassified stocks
- Show stocks in Unclassified above 50DMA with positive 1M return
- Find Unclassified stocks with improving momentum and reasonable valuation
Related screen ideas
- View Unclassified stocks
- View stocks
- Find stocks above 50DMA
- Compare PLPHAR-RE with other Unclassified stocks
Data snapshot: latest available. Not investment advice.